HIV Co-infections

This factsheet highlights the barriers that prevent equitable access to innovative and quality-assured medicines for some selected HIV co-infections.

Stocktake of DFID’s work on key populations, July 2014

Entitled “Increasing DFID’s contribution to Addressing HIV among key populations” and building on our earlier critique of DFID’s position paper on HIV and AIDS, the report makes a series of recommendations about how STOPAIDS members believe DFID can work more effectively to advance the rights of communities who are disproportionately affected by AIDS, notably men who … Continued